DR. CONINX
ActiveSummary
DR. CONINX has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.3m and a net result of €325,507. Equity is growing by about 10% per year across the filed financial years. Its solvency ranks better than 75% of 20,511 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
27-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 27 days late
2025
31-12
Financial
Highest result from 2018 to 2025net €325,507 ▲27.2%
Operating result €453,199, net result €325,507, both a record.
27-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 27 days late
2024
27-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 27 days late
2023
30-10
NBB filing
Annual accounts filed
financial year 2022 · micro format · 91 days late
2022
31-12
Financial
Equity above €1mequity €1.2m ▲23.4%
A profit in every financial year since 2018 builds equity to €1.2m.
02-11
NBB filing
Annual accounts filed
financial year 2021 · micro format · 94 days late
2021
23-08
NBB filing
Annual accounts filed
financial year 2020 · micro format · 23 days late
2020
06-08
NBB filing
Annual accounts filed
financial year 2019 · micro format · 6 days late
2019
04-06
NBB filing
Annual accounts filed
financial year 2018 · micro format
2018
05-06
NBB filing
Annual accounts filed
financial year 2017 · micro format
2017
28-06
NBB filing
Annual accounts filed
financial year 2016 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 25 annual accounts filed, the latest 10 are here; all 25 are under Financials.
0 of 5 deeds read
About the unread acts
We know of 5 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.